The gateway to the largest hospital in Catalonia.
The gateway to research and medical innovation.
The gateway to the oncology center of excellence.
The space for specialized and top-level care of the multiple sclerosis.
We are Vall d'Hebron
Activate and deactivate items in the key to see those that interest you.
Use the list to answer your health-related questions.
Learn more about cancer. Find out about the risk factors and specialist care we provide.
We make life easier. We can help with all administrative processes and get you the information you need during your time in hospital and...
Donate your time through a voluntary organisation or tell us about your experience at the hospital.
If you are considering where to do your residency, we can offer a wide range of clinical specialisations when you train at Vall d’Hebron...
Last year, the hospital performed 114 cornea transplants, beating its own record. The Ophthalmology Department offers all available...
Maria Salvado has worked in the Vall d’Hebron Research Institute and the Neurology Department at Hospital Universitari Vall d’Hebron in Barcelona since 2012, where his clinical work focuses on treatment of neuromuscular disorders.
She works as a neurologist at the Neuromuscular and Rare Diseases Unit of Vall d'Hebron Hospital and as a researcher in the Peripheral Nervous System Disease Research Laboratory (VHIR), currently led by Dr. R. Juntas-Morales.
The main lines of this research group are based on the identification of new biomarkers and genetic determinants in familial and sporadic forms of amyotrophic lateral sclerosis (ALS), autoimmune myasthenia gravis (MG), and genetic-based myopathies and neuropathies. She is also one of the professionals in the European Network for Neuromuscular and Rare Diseases (EURO-NMD ERN) and the European Network for rare neurological diseases (ERN-RND). Hospital Vall d’Hebron is member of these ERNs.
She is co-author of more than 20 peer-reviewed articles and in February 2020, she obtained her PhD title from the Autonomous University of Barcelona for her thesis entitled "Study of genetic factors that influence the familial and sporadic forms of myasthenia gravis autoimmune ”(Teseo, TDX). In 2013, she was awarded the Scientific Poster Award at the International Symposium for ALS (MNDA).
She is a co-investigator for several grants, research projects and clinical trials, including FIS (Fondo de Investigación Sanitarias) and MINECO (Ministerio de Economía y Competitividad) grants. These grants are for studies of rare neurological diseases such as ALS, myasthenia gravis, familial amyloid polyneuropathy (Corino-Andrade disease), mitochondrial diseases and chronic inflammatory demyelinating polyradiculoneuropathy (CIDP).